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Figure S2
Sequence alignment and structural superposition of human cereblon and MsCI4 in complex Glutarimide (Piperidine-2,6-dione) 28 ± 5.0
Maleimide (Pyrrol-2,5-dione) 35 ± 3.1
DL-Aminoglutethimide 39 ± 3.8
Hydantoin (Imidazolidine-2,4-dione) 43 ± 10.7
γ-Butyrolactam (Pyrrolidin-2-one) 57 ± 11.6
Azetidin-2-one 77 ± 11.0
Dihydrouracil (Hexahydropyrimidine-2,4-dione) 88 ± 6.8
Ethosuximide (3-Ethyl-3-methylsuccinimide) 136 ± 11.6
Thiazolidine-2,4-dione 137 ± 15.9
Thymidine 204 ± 34.5
Thymine (5-Methylpyrimidine-2,4-dione) 478 ± 41.6
N-Acetylurea 522 ± 53.5
Acetamide > 1,000 1-Azo-2-Cyclooctanone > 1,000
Creatinine (2-Imino-N-methylhydantoin) > 1,000
Cytosine > 1,000
5,5-Dimethyl-oxazolidine-2,4-dione > 1,000 ε-Caprolactam > 1,000
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Table S1
All substances addressed in this study, sorted by affinity for MsCI4. Piperidine > 1,000
Pseudouridine > 1,000
Pyrrolidine-2-thione > 1,000
Succinic Anhydride > 1,000
Glutethimide unavailable
Nitrofurantoin n.d.
Oxazolidine-2,4-dione unavailable
Rogletimide unavailable 5OH1  5OH2  5OH3  5OH4  5OH7  5OH8  5OH9  5OHA  5OHB 
